BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 8:28:55 AM | Browse: 265 | Download: 688
 |
Received |
|
2024-04-23 15:39 |
|
Peer-Review Started |
|
2024-04-23 15:39 |
|
First Decision by Editorial Office Director |
|
2024-07-25 06:05 |
|
Return for Revision |
|
2024-07-27 14:16 |
|
Revised |
|
2024-08-08 14:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-08-19 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-19 06:51 |
|
Articles in Press |
|
2024-08-19 06:51 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-21 10:16 |
|
Publish the Manuscript Online |
|
2024-08-29 08:28 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dong-Ling Wan and Li-Qi Sun |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li-Qi Sun, MD, Doctor, Doctor, Department of Gastroenterology, Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. zjhzslqsmmu@foxmail.com |
| Key Words |
Hepatocellular carcinoma; Hepatitis B virus; Hepatectomy; Antiviral therapy; Hepatitis B virus-DNA; Hepatitis B virus-DNA |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the most common and highly fatal malignancies worldwide and is usually associated with hepatitis B virus (HBV) infection. Hepatectomy is a widely accepted curative treatment for HCC, but the long-term survival rate is still unsatisfactory due to the high recurrence rate after resection. Preoperative or postoperative antiviral therapy plays an important role in improving the prognosis for HBV-related HCC patients who underwent hepatectomy. Therefore, we explored when antiviral therapy is more appropriate and whether perioperative rescue antiviral therapy can achieve the effect of preoperative long-term antiviral therapy in the paper. |
| Publish Date |
2024-08-29 08:28 |
| Citation |
Wan DL, Sun LQ. Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy. World J Clin Oncol 2024; 15(9): 1251-1255 |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i9/1251.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i9.1251 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
